US Stock MarketDetailed Quotes

NewAmsterdam Pharma (NAMS)

Watchlist
  • 29.720
  • -1.740-5.53%
Close Apr 24 16:00 ET
  • 29.720
  • 0.0000.00%
Post 18:25 ET
3.42BMarket Cap-17.28P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NewAmsterdam Pharma (NAMS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-50.61%22.5M
-99.75%32K
-98.80%348K
740.06%19.15M
112.56%2.98M
223.37%45.56M
1,490.54%12.77M
889.83%29.11M
32.73%2.28M
-83.76%1.4M
Operating revenue
-50.61%22.5M
-99.75%32K
-98.80%348K
740.06%19.15M
112.56%2.98M
223.37%45.56M
1,490.54%12.77M
889.83%29.11M
32.73%2.28M
-83.76%1.4M
Cost of revenue
Gross profit
Operating expense
11.87%248.19M
17.88%66.01M
2.54%55.49M
-0.13%54.78M
26.41%71.9M
12.58%221.85M
-3.21%56M
5.64%54.11M
34.72%54.85M
20.37%56.88M
Selling and administrative expenses
50.97%106.35M
29.91%27.42M
33.17%24.52M
65.49%27.26M
87.86%27.15M
87.19%70.45M
27.39%21.11M
134.46%18.41M
158.43%16.48M
111.39%14.45M
-Selling and marketing expense
----
----
----
----
----
----
----
210.51%3.55M
650.96%3.52M
559.39%4.08M
-General and administrative expense
50.97%106.35M
29.91%27.42M
33.17%24.52M
65.49%27.26M
87.86%27.15M
87.19%70.45M
12.28%21.11M
174.36%18.41M
178.95%16.48M
132.40%14.45M
Research and development costs
-6.32%141.83M
10.60%38.59M
-13.25%30.97M
-28.30%27.52M
5.47%44.75M
-5.03%151.41M
-15.49%34.9M
-17.68%35.7M
11.76%38.38M
4.97%42.43M
Operating profit
-28.02%-225.68M
-52.63%-65.98M
-120.55%-55.14M
32.22%-35.64M
-24.23%-68.93M
3.65%-176.29M
24.24%-43.23M
48.22%-25M
-34.81%-52.58M
-43.63%-55.48M
Net non-operating interest income expense
63.45%27.59M
44.33%6.47M
51.09%6.71M
44.87%7.06M
138.44%7.35M
49.61%16.88M
-48.16%4.49M
149.05%4.44M
330.97%4.87M
1,193.26%3.08M
Non-operating interest income
63.45%27.59M
44.33%6.47M
51.09%6.71M
44.87%7.06M
138.44%7.35M
49.61%16.88M
68.10%4.49M
45.24%4.44M
5.57%4.87M
226.94%3.08M
Non-operating interest expense
----
----
----
----
----
--0
----
----
----
----
Total other finance cost
----
----
----
----
----
----
----
-10.98%1.14M
-66.21%1.18M
-27.10%893K
Other net income (expense)
93.03%-5.73M
71.15%-15.42M
-702.63%-23.58M
28.95%11.22M
153.29%22.05M
-1,472.73%-82.19M
-4,931.36%-53.43M
717.03%3.91M
2,161.14%8.7M
-1,231.02%-41.37M
Gain on sale of security
78.49%-9.72M
43.82%-15.42M
-352.78%-23.57M
100.21%11.22M
155.27%18.06M
-810.91%-45.18M
-3,347.61%-27.44M
1,570.98%9.33M
1,427.49%5.6M
-951.03%-32.67M
Special income (charges)
110.79%3.99M
100.00%1K
99.98%-1K
--0
145.87%3.99M
-13,813.53%-37.01M
---25.99M
---5.41M
--3.1M
---8.7M
-Less：Restructuring and merger&acquisition
-110.79%-3.99M
--0
--0
--0
-145.87%-3.99M
13,813.53%37.01M
--25.99M
--5.41M
---3.1M
--8.7M
-Gain on sale of property,plant,equipment
----
----
---1K
----
----
----
----
--0
----
----
Income before tax
15.64%-203.82M
18.72%-74.92M
-332.51%-72.01M
55.48%-17.36M
57.85%-39.53M
-36.57%-241.6M
-86.34%-92.18M
64.68%-16.65M
-1.87%-39.01M
-123.16%-93.77M
Income tax
0
0
0
0
0
-103.70%-1K
0
-1K
0
0
Net income
15.64%-203.82M
18.72%-74.92M
-332.54%-72.01M
55.48%-17.36M
57.85%-39.53M
-36.54%-241.6M
-86.23%-92.18M
64.68%-16.65M
-1.87%-39.01M
-123.16%-93.77M
Net income continuous Operations
15.64%-203.82M
18.72%-74.92M
-332.54%-72.01M
55.48%-17.36M
57.85%-39.53M
-36.54%-241.6M
-86.23%-92.18M
64.68%-16.65M
-1.87%-39.01M
-123.16%-93.77M
Minority interest income
Net income attributable to the parent company
15.64%-203.82M
18.72%-74.92M
-332.54%-72.01M
55.48%-17.36M
57.85%-39.53M
-36.54%-241.6M
-86.23%-92.18M
64.68%-16.65M
-1.87%-39.01M
-123.16%-93.77M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
15.64%-203.82M
18.72%-74.92M
-332.54%-72.01M
55.48%-17.36M
57.85%-39.53M
-36.54%-241.6M
-86.23%-92.18M
64.68%-16.65M
-1.87%-39.01M
-123.16%-93.77M
Basic earnings per share
32.81%-1.72
33.68%-0.63
-238.89%-0.61
63.41%-0.15
67.92%-0.34
-19.07%-2.56
-58.33%-0.95
68.42%-0.18
12.77%-0.41
-107.84%-1.06
Diluted earnings per share
32.81%-1.72
33.68%-0.63
-238.89%-0.61
63.41%-0.15
67.92%-0.34
-19.07%-2.56
-58.33%-0.95
68.42%-0.18
12.77%-0.41
-107.84%-1.06
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -50.61%22.5M-99.75%32K-98.80%348K740.06%19.15M112.56%2.98M223.37%45.56M1,490.54%12.77M889.83%29.11M32.73%2.28M-83.76%1.4M
Operating revenue -50.61%22.5M-99.75%32K-98.80%348K740.06%19.15M112.56%2.98M223.37%45.56M1,490.54%12.77M889.83%29.11M32.73%2.28M-83.76%1.4M
Cost of revenue
Gross profit
Operating expense 11.87%248.19M17.88%66.01M2.54%55.49M-0.13%54.78M26.41%71.9M12.58%221.85M-3.21%56M5.64%54.11M34.72%54.85M20.37%56.88M
Selling and administrative expenses 50.97%106.35M29.91%27.42M33.17%24.52M65.49%27.26M87.86%27.15M87.19%70.45M27.39%21.11M134.46%18.41M158.43%16.48M111.39%14.45M
-Selling and marketing expense ----------------------------210.51%3.55M650.96%3.52M559.39%4.08M
-General and administrative expense 50.97%106.35M29.91%27.42M33.17%24.52M65.49%27.26M87.86%27.15M87.19%70.45M12.28%21.11M174.36%18.41M178.95%16.48M132.40%14.45M
Research and development costs -6.32%141.83M10.60%38.59M-13.25%30.97M-28.30%27.52M5.47%44.75M-5.03%151.41M-15.49%34.9M-17.68%35.7M11.76%38.38M4.97%42.43M
Operating profit -28.02%-225.68M-52.63%-65.98M-120.55%-55.14M32.22%-35.64M-24.23%-68.93M3.65%-176.29M24.24%-43.23M48.22%-25M-34.81%-52.58M-43.63%-55.48M
Net non-operating interest income expense 63.45%27.59M44.33%6.47M51.09%6.71M44.87%7.06M138.44%7.35M49.61%16.88M-48.16%4.49M149.05%4.44M330.97%4.87M1,193.26%3.08M
Non-operating interest income 63.45%27.59M44.33%6.47M51.09%6.71M44.87%7.06M138.44%7.35M49.61%16.88M68.10%4.49M45.24%4.44M5.57%4.87M226.94%3.08M
Non-operating interest expense ----------------------0----------------
Total other finance cost -----------------------------10.98%1.14M-66.21%1.18M-27.10%893K
Other net income (expense) 93.03%-5.73M71.15%-15.42M-702.63%-23.58M28.95%11.22M153.29%22.05M-1,472.73%-82.19M-4,931.36%-53.43M717.03%3.91M2,161.14%8.7M-1,231.02%-41.37M
Gain on sale of security 78.49%-9.72M43.82%-15.42M-352.78%-23.57M100.21%11.22M155.27%18.06M-810.91%-45.18M-3,347.61%-27.44M1,570.98%9.33M1,427.49%5.6M-951.03%-32.67M
Special income (charges) 110.79%3.99M100.00%1K99.98%-1K--0145.87%3.99M-13,813.53%-37.01M---25.99M---5.41M--3.1M---8.7M
-Less：Restructuring and merger&acquisition -110.79%-3.99M--0--0--0-145.87%-3.99M13,813.53%37.01M--25.99M--5.41M---3.1M--8.7M
-Gain on sale of property,plant,equipment -----------1K------------------0--------
Income before tax 15.64%-203.82M18.72%-74.92M-332.51%-72.01M55.48%-17.36M57.85%-39.53M-36.57%-241.6M-86.34%-92.18M64.68%-16.65M-1.87%-39.01M-123.16%-93.77M
Income tax 00000-103.70%-1K0-1K00
Net income 15.64%-203.82M18.72%-74.92M-332.54%-72.01M55.48%-17.36M57.85%-39.53M-36.54%-241.6M-86.23%-92.18M64.68%-16.65M-1.87%-39.01M-123.16%-93.77M
Net income continuous Operations 15.64%-203.82M18.72%-74.92M-332.54%-72.01M55.48%-17.36M57.85%-39.53M-36.54%-241.6M-86.23%-92.18M64.68%-16.65M-1.87%-39.01M-123.16%-93.77M
Minority interest income
Net income attributable to the parent company 15.64%-203.82M18.72%-74.92M-332.54%-72.01M55.48%-17.36M57.85%-39.53M-36.54%-241.6M-86.23%-92.18M64.68%-16.65M-1.87%-39.01M-123.16%-93.77M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 15.64%-203.82M18.72%-74.92M-332.54%-72.01M55.48%-17.36M57.85%-39.53M-36.54%-241.6M-86.23%-92.18M64.68%-16.65M-1.87%-39.01M-123.16%-93.77M
Basic earnings per share 32.81%-1.7233.68%-0.63-238.89%-0.6163.41%-0.1567.92%-0.34-19.07%-2.56-58.33%-0.9568.42%-0.1812.77%-0.41-107.84%-1.06
Diluted earnings per share 32.81%-1.7233.68%-0.63-238.89%-0.6163.41%-0.1567.92%-0.34-19.07%-2.56-58.33%-0.9568.42%-0.1812.77%-0.41-107.84%-1.06
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -